Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs

Published July 1, 2026 9:00am ET



An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks the beginning of a financial one.

Many of the 50 million Americans living with lupus, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, psoriasis, or other autoimmune diseases rely on expensive therapies and specialty care to manage their conditions and prevent flare-ups. Yet even with insurance, they often struggle to afford the care they need.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.